Tscan Therapeutics, Inc. · NASDAQ:TCRX
Adage Capital Partners Gp, L.L.C. reported a 7.13% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Partners Gp, L.L.C. reported a 7.13% stake in Tscan Therapeutics, Inc., 3,500,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 7.13%
- Shares
- 3,500,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 7.13% | 3,500,000 |
| Adage Capital Partners GP, L.L.C. | 0% | 0 |
| Robert Atchinson | 7.13% | 3,500,000 |
| Phillip Gross | 7.13% | 3,500,000 |
Source
Related
- Tscan Therapeutics, Inc.
- Adage Capital Partners Gp, L.L.C.
- Tscan Therapeutics, Inc. shareholders
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026